<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-10-07" version="211">
<accession>P42166</accession>
<accession>P08918</accession>
<accession>P08919</accession>
<accession>Q14860</accession>
<accession>Q16295</accession>
<name>LAP2A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Lamina-associated polypeptide 2, isoform alpha</fullName>
</recommendedName>
<alternativeName>
<fullName>Thymopoietin isoform alpha</fullName>
<shortName>TP alpha</shortName>
</alternativeName>
<alternativeName>
<fullName>Thymopoietin-related peptide isoform alpha</fullName>
<shortName>TPRP isoform alpha</shortName>
</alternativeName>
<component>
<recommendedName>
<fullName>Thymopoietin</fullName>
<shortName>TP</shortName>
</recommendedName>
<alternativeName>
<fullName>Splenin</fullName>
</alternativeName>
</component>
<component>
<recommendedName>
<fullName>Thymopentin</fullName>
</recommendedName>
<alternativeName>
<fullName>TP5</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">TMPO</name>
<name type="synonym">LAP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="6283" last="6287">
<title>Three distinct human thymopoietins are derived from alternatively spliced mRNAs.</title>
<authorList>
<person name="Harris C.A."/>
<person name="Andryuk P.J."/>
<person name="Cline S.W."/>
<person name="Chan H.K."/>
<person name="Natarajan A."/>
<person name="Siekierka J.J."/>
<person name="Goldstein G."/>
</authorList>
<dbReference type="PubMed" id="7517549"/>
<dbReference type="DOI" id="10.1073/pnas.91.14.6283"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA AND GAMMA)</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Genomics" volume="28" first="198" last="205">
<title>Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2.</title>
<authorList>
<person name="Harris C.A."/>
<person name="Andryuk P.J."/>
<person name="Cline S.W."/>
<person name="Siekierka J.J."/>
<person name="Goldstein G."/>
</authorList>
<dbReference type="PubMed" id="8530026"/>
<dbReference type="DOI" id="10.1006/geno.1995.1131"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS ALPHA; BETA AND GAMMA)</scope>
<scope>VARIANT GLU-599</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Biochem. Mol. Biol. Int." volume="34" first="927" last="933">
<title>A new thymopoietin precursor gene from human thymus.</title>
<authorList>
<person name="Hara H."/>
<person name="Hayashi K."/>
<person name="Ohta K."/>
<person name="Itoh N."/>
<person name="Ohta M."/>
</authorList>
<dbReference type="PubMed" id="7703909"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-526</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2008-03" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Vousden K.H."/>
<person name="Lukashchuk N."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-13; 127-139; 254-264; 417-427 AND 526-535</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lung carcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="3545" last="3549">
<title>Isolation and complete amino acid sequence of human thymopoietin and splenin.</title>
<authorList>
<person name="Audhya T."/>
<person name="Schlesinger D.H."/>
<person name="Goldstein G."/>
</authorList>
<dbReference type="PubMed" id="3473468"/>
<dbReference type="DOI" id="10.1073/pnas.84.11.3545"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="6249" last="6249">
<authorList>
<person name="Goldstein G."/>
<person name="Schlesinger D.H."/>
<person name="Audhya T."/>
</authorList>
<dbReference type="PubMed" id="8016147"/>
<dbReference type="DOI" id="10.1073/pnas.91.13.6249"/>
</citation>
<scope>ERRATUM OF PUBMED:3473468</scope>
<scope>RETRACTION NOTICE OF PUBMED:3473468</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="4887" last="4902">
<title>Detergent-salt resistance of LAP2alpha in interphase nuclei and phosphorylation-dependent association with chromosomes early in nuclear assembly implies functions in nuclear structure dynamics.</title>
<authorList>
<person name="Dechat T."/>
<person name="Gotzmann J."/>
<person name="Stockinger A."/>
<person name="Harris C.A."/>
<person name="Talle M.A."/>
<person name="Siekierka J.J."/>
<person name="Foisner R."/>
</authorList>
<dbReference type="PubMed" id="9707448"/>
<dbReference type="DOI" id="10.1093/emboj/17.16.4887"/>
</citation>
<scope>INTERACTION WITH CHROMOSOMES</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Cell Sci." volume="113" first="3473" last="3484">
<title>Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins.</title>
<authorList>
<person name="Dechat T."/>
<person name="Korbei B."/>
<person name="Vaughan O.A."/>
<person name="Vlcek S."/>
<person name="Hutchison C.J."/>
<person name="Foisner R."/>
</authorList>
<dbReference type="PubMed" id="10984438"/>
</citation>
<scope>INTERACTION WITH LMNA</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="4401" last="4413">
<title>Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein.</title>
<authorList>
<person name="Markiewicz E."/>
<person name="Dechat T."/>
<person name="Foisner R."/>
<person name="Quinlan R.A."/>
<person name="Hutchison C.J."/>
</authorList>
<dbReference type="PubMed" id="12475961"/>
<dbReference type="DOI" id="10.1091/mbc.e02-07-0450"/>
</citation>
<scope>INTERACTION WITH LMNA AND RB1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Electrophoresis" volume="28" first="2027" last="2034">
<title>Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.</title>
<authorList>
<person name="Giorgianni F."/>
<person name="Zhao Y."/>
<person name="Desiderio D.M."/>
<person name="Beranova-Giorgianni S."/>
</authorList>
<dbReference type="PubMed" id="17487921"/>
<dbReference type="DOI" id="10.1002/elps.200600782"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Prostate cancer</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
<title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
<authorList>
<person name="Carrascal M."/>
<person name="Ovelleiro D."/>
<person name="Casas V."/>
<person name="Gay M."/>
<person name="Abian J."/>
</authorList>
<dbReference type="PubMed" id="19367720"/>
<dbReference type="DOI" id="10.1021/pr800500r"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74; SER-351 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-57; SER-66; SER-67; THR-74; SER-79; THR-160; THR-164; SER-351; SER-370 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-67; THR-74; SER-79; THR-154; THR-160; SER-351 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-656</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-74; SER-156; THR-160; SER-351; SER-354; SER-370 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59; THR-74; SER-351 AND SER-354</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-67; THR-74; SER-79; SER-156; THR-160; THR-164; SER-168; SER-272; SER-351; SER-354; SER-370 AND SER-424</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-67; THR-74; THR-160; SER-312 AND SER-351</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="Mol. Genet. Genomic Med." volume="4" first="617" last="623">
<title>Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy.</title>
<authorList>
<person name="Nouhravesh N."/>
<person name="Ahlberg G."/>
<person name="Ghouse J."/>
<person name="Andreasen C."/>
<person name="Svendsen J.H."/>
<person name="Haunsoe S."/>
<person name="Bundgaard H."/>
<person name="Weeke P.E."/>
<person name="Olesen M.S."/>
</authorList>
<dbReference type="PubMed" id="27896284"/>
<dbReference type="DOI" id="10.1002/mgg3.245"/>
</citation>
<scope>LACK OF INVOLVEMENT IN DILATED CARDIOMYOPATHY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Nature" volume="549" first="101" last="105">
<title>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.</title>
<authorList>
<person name="Burr M.L."/>
<person name="Sparbier C.E."/>
<person name="Chan Y.C."/>
<person name="Williamson J.C."/>
<person name="Woods K."/>
<person name="Beavis P.A."/>
<person name="Lam E.Y.N."/>
<person name="Henderson M.A."/>
<person name="Bell C.C."/>
<person name="Stolzenburg S."/>
<person name="Gilan O."/>
<person name="Bloor S."/>
<person name="Noori T."/>
<person name="Morgens D.W."/>
<person name="Bassik M.C."/>
<person name="Neeson P.J."/>
<person name="Behren A."/>
<person name="Darcy P.K."/>
<person name="Dawson S.J."/>
<person name="Voskoboinik I."/>
<person name="Trapani J.A."/>
<person name="Cebon J."/>
<person name="Lehner P.J."/>
<person name="Dawson M.A."/>
</authorList>
<dbReference type="PubMed" id="28813417"/>
<dbReference type="DOI" id="10.1038/nature23643"/>
</citation>
<scope>INTERACTION WITH CMTM6</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="4399" last="4407">
<title>Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA.</title>
<authorList>
<person name="Cai M."/>
<person name="Huang Y."/>
<person name="Ghirlando R."/>
<person name="Wilson K.L."/>
<person name="Craigie R."/>
<person name="Clore G.M."/>
</authorList>
<dbReference type="PubMed" id="11500367"/>
<dbReference type="DOI" id="10.1093/emboj/20.16.4399"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-169</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2001" name="Structure" volume="9" first="503" last="511">
<title>Structural characterization of the LEM motif common to three human inner nuclear membrane proteins.</title>
<authorList>
<person name="Laguri C."/>
<person name="Gilquin B."/>
<person name="Wolff N."/>
<person name="Romi-Lebrun R."/>
<person name="Courchay K."/>
<person name="Callebaut I."/>
<person name="Worman H.J."/>
<person name="Zinn-Justin S."/>
</authorList>
<dbReference type="PubMed" id="11435115"/>
<dbReference type="DOI" id="10.1016/s0969-2126(01)00611-6"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-57 AND 103-159</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="26" first="566" last="574">
<title>Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.</title>
<authorList>
<person name="Taylor M.R."/>
<person name="Slavov D."/>
<person name="Gajewski A."/>
<person name="Vlcek S."/>
<person name="Ku L."/>
<person name="Fain P.R."/>
<person name="Carniel E."/>
<person name="Di Lenarda A."/>
<person name="Sinagra G."/>
<person name="Boucek M.M."/>
<person name="Cavanaugh J."/>
<person name="Graw S.L."/>
<person name="Ruegg P."/>
<person name="Feiger J."/>
<person name="Zhu X."/>
<person name="Ferguson D.A."/>
<person name="Bristow M.R."/>
<person name="Gotzmann J."/>
<person name="Foisner R."/>
<person name="Mestroni L."/>
</authorList>
<dbReference type="PubMed" id="16247757"/>
<dbReference type="DOI" id="10.1002/humu.20250"/>
</citation>
<scope>VARIANT CYS-690</scope>
<scope>CHARACTERIZATION OF VARIANT CYS-690</scope>
</reference>
<comment type="function">
<text>May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. Plays an important role, together with LMNA, in the nuclear anchorage of RB1.</text>
</comment>
<comment type="function">
<text>TP and TP5 may play a role in T-cell development and function. TP5 is an immunomodulating pentapeptide.</text>
</comment>
<comment type="subunit">
<text evidence="20 21 23 25">Interacts with LMNA, BANF1 and RB1 and with chromosomes. Associates directly or indirectly with lamins at specific cell-cycle stages. Interacts with CMTM6 (PubMed:28813417).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-395393">
<id>P42166</id>
</interactant>
<interactant intactId="EBI-351935">
<id>P02545</id>
<label>LMNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Chromosome</location>
</subcellularLocation>
<text>Expressed diffusely throughout the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P42166-1</id>
<name>Alpha</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P42167-1</id>
<name>Beta</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>P42167-2</id>
<name>Gamma</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>P42167-3</id>
<name>Zeta</name>
<sequence type="external"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in many tissues. Most abundant in adult thymus and fetal liver.</text>
</comment>
<comment type="domain">
<text>The N-terminal part contains two structurally independent, non-interacting domains: LEM-like (also called LAP2-N or LEM-D) and LEM (also called LAP2-C or LEM-B). LEM-like binds DNA while LEM interacts with BANF1.</text>
</comment>
<comment type="domain">
<text evidence="15">The C-terminal domain forms a four-stranded coiled coil.</text>
</comment>
<comment type="PTM">
<text evidence="25">Phosphorylated in a mitose-specific manner.</text>
</comment>
<comment type="pharmaceutical">
<text>TP5 is available under the names Timunox (Cilag), Sintomodulina (Italofarmaco) and Mepentil (Recordati). Used in primary and secondary immune deficiencies, autoimmunity, infections and cancer.</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the LEM family.</text>
</comment>
<comment type="caution">
<text evidence="22 28">TMPO was originally considered a good candidate for dilated cardiomyopathy, and variant Cys-290 has been reported to be a likely pathogenic mutation (PubMed:16247757). However, Cys-290 has a high allele frequency and individuals homozygous for the variant have been reported in ExAC database. Therefore, this variant has been reclassified as a likely benign polymorphism (PubMed:27896284).</text>
</comment>
<dbReference type="EMBL" id="U09086">
<property type="protein sequence ID" value="AAB60329.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U18270">
<property type="protein sequence ID" value="AAB60433.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18266">
<property type="protein sequence ID" value="AAB60433.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18267">
<property type="protein sequence ID" value="AAB60433.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18268">
<property type="protein sequence ID" value="AAB60433.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76736">
<property type="protein sequence ID" value="AAB33958.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9064.1">
<molecule id="P42166-1"/>
</dbReference>
<dbReference type="PIR" id="G01161">
<property type="entry name" value="G01161"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003267.1">
<molecule id="P42166-1"/>
<property type="nucleotide sequence ID" value="NM_003276.2"/>
</dbReference>
<dbReference type="PDB" id="1GJJ">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-168"/>
</dbReference>
<dbReference type="PDB" id="1H9E">
<property type="method" value="NMR"/>
<property type="chains" value="A=2-57"/>
</dbReference>
<dbReference type="PDB" id="1H9F">
<property type="method" value="NMR"/>
<property type="chains" value="A=103-159"/>
</dbReference>
<dbReference type="PDBsum" id="1GJJ"/>
<dbReference type="PDBsum" id="1H9E"/>
<dbReference type="PDBsum" id="1H9F"/>
<dbReference type="BMRB" id="P42166"/>
<dbReference type="SMR" id="P42166"/>
<dbReference type="BioGRID" id="112967">
<property type="interactions" value="414"/>
</dbReference>
<dbReference type="IntAct" id="P42166">
<property type="interactions" value="52"/>
</dbReference>
<dbReference type="MINT" id="P42166"/>
<dbReference type="STRING" id="9606.ENSP00000266732"/>
<dbReference type="GlyGen" id="P42166">
<property type="glycosylation" value="2 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P42166"/>
<dbReference type="MetOSite" id="P42166"/>
<dbReference type="SwissPalm" id="P42166"/>
<dbReference type="BioMuta" id="TMPO"/>
<dbReference type="DMDM" id="1174689"/>
<dbReference type="CPTAC" id="CPTAC-949"/>
<dbReference type="EPD" id="P42166"/>
<dbReference type="jPOST" id="P42166"/>
<dbReference type="MassIVE" id="P42166"/>
<dbReference type="PaxDb" id="P42166"/>
<dbReference type="PeptideAtlas" id="P42166"/>
<dbReference type="PRIDE" id="P42166"/>
<dbReference type="ProteomicsDB" id="55488">
<molecule id="P42166-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="2387">
<property type="antibodies" value="372 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7112"/>
<dbReference type="Ensembl" id="ENST00000266732">
<molecule id="P42166-1"/>
<property type="protein sequence ID" value="ENSP00000266732"/>
<property type="gene ID" value="ENSG00000120802"/>
</dbReference>
<dbReference type="GeneID" id="7112"/>
<dbReference type="UCSC" id="uc001tfh.3">
<molecule id="P42166-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7112"/>
<dbReference type="DisGeNET" id="7112"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000120802.13"/>
<dbReference type="GeneCards" id="TMPO"/>
<dbReference type="GeneReviews" id="TMPO"/>
<dbReference type="HGNC" id="HGNC:11875">
<property type="gene designation" value="TMPO"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000120802">
<property type="expression patterns" value="Tissue enhanced (lymphoid)"/>
</dbReference>
<dbReference type="MalaCards" id="TMPO"/>
<dbReference type="MIM" id="188380">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P42166"/>
<dbReference type="OpenTargets" id="ENSG00000120802"/>
<dbReference type="PharmGKB" id="PA36576"/>
<dbReference type="eggNOG" id="ENOG502QWCI">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154098"/>
<dbReference type="HOGENOM" id="CLU_397364_0_0_1"/>
<dbReference type="InParanoid" id="P42166"/>
<dbReference type="OrthoDB" id="323585at2759"/>
<dbReference type="PhylomeDB" id="P42166"/>
<dbReference type="TreeFam" id="TF328426"/>
<dbReference type="PathwayCommons" id="P42166"/>
<dbReference type="BioGRID-ORCS" id="7112">
<property type="hits" value="11 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TMPO">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P42166"/>
<dbReference type="GeneWiki" id="Thymopoietin"/>
<dbReference type="GenomeRNAi" id="7112"/>
<dbReference type="Pharos" id="P42166">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="P42166">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000120802">
<property type="expression patterns" value="Expressed in intestine and 236 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P42166">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P42166">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005521">
<property type="term" value="F:lamin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.720.40">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR021623">
<property type="entry name" value="LAP2alpha_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR013146">
<property type="entry name" value="LEM-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011015">
<property type="entry name" value="LEM/LEM-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003887">
<property type="entry name" value="LEM_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF11560">
<property type="entry name" value="LAP2alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03020">
<property type="entry name" value="LEM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08198">
<property type="entry name" value="Thymopoietin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00540">
<property type="entry name" value="LEM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01261">
<property type="entry name" value="Thymopoietin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF63451">
<property type="entry name" value="SSF63451"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50954">
<property type="entry name" value="LEM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50955">
<property type="entry name" value="LEM_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0122">Cardiomyopathy</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0582">Pharmaceutical</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="initiator methionine" description="Removed" evidence="26">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Lamina-associated polypeptide 2, isoform alpha" id="PRO_0000017674">
<location>
<begin position="2"/>
<end position="694"/>
</location>
</feature>
<feature type="peptide" description="Thymopoietin" id="PRO_0000017675">
<location>
<begin position="2"/>
<end position="50"/>
</location>
</feature>
<feature type="peptide" description="Thymopentin" id="PRO_0000017676">
<location>
<begin position="33"/>
<end position="37"/>
</location>
</feature>
<feature type="domain" description="LEM-like" evidence="18 19">
<location>
<begin position="5"/>
<end position="48"/>
</location>
</feature>
<feature type="domain" description="LEM" evidence="18">
<location>
<begin position="109"/>
<end position="153"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="49"/>
<end position="108"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="15">
<location>
<begin position="558"/>
<end position="657"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="17">
<location>
<begin position="190"/>
<end position="196"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="57"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="59"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 13 14">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 13 14">
<location>
<position position="67"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 7 8 10 11 12 13 14">
<location>
<position position="74"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 13">
<location>
<position position="79"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="16">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="16">
<location>
<position position="88"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13">
<location>
<position position="156"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="159"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 10 11 13 14">
<location>
<position position="160"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 13">
<location>
<position position="164"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="272"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 7 8 10 11 12 13 14">
<location>
<position position="351"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13">
<location>
<position position="354"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 11 13">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 7 8 10 11 13">
<location>
<position position="424"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35998138." id="VAR_049773">
<original>L</original>
<variation>R</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35645287." id="VAR_049774">
<original>S</original>
<variation>A</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35969221." id="VAR_049775">
<original>T</original>
<variation>S</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11838270." id="VAR_049776">
<original>K</original>
<variation>E</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35761089." id="VAR_049777">
<original>K</original>
<variation>N</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17459334." id="VAR_005635" evidence="24">
<original>Q</original>
<variation>E</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; affects the interaction with LMNA; dbSNP:rs17028450." id="VAR_049778" evidence="22">
<original>R</original>
<variation>C</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="8"/>
<end position="11"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="13"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="34"/>
<end position="39"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="46"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="117"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="139"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="147"/>
<end position="152"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GJJ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1H9E"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1H9F"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61033"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255"/>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00313"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00314"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10984438"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12475961"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247757"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28813417"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8530026"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9707448"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27896284"/>
</source>
</evidence>
<sequence length="694" mass="75492" checksum="1B514B0FB61D0D75" modified="2007-01-23" version="2">MPEFLEDPSVLTKDKLKSELVANNVTLPAGEQRKDVYVQLYLQHLTARNRPPLPAGTNSKGPPDFSSDEEREPTPVLGSGAAAAGRSRAAVGRKATKKTDKPRQEDKDDLDVTELTNEDLLDQLVKYGVNPGPIVGTTRKLYEKKLLKLREQGTESRSSTPLPTISSSAENTRQNGSNDSDRYSDNEEGKKKEHKKVKSTRDIVPFSELGTTPSGGGFFQGISFPEISTRPPLGSTELQAAKKVHTSKGDLPREPLVATNLPGRGQLQKLASERNLFISCKSSHDRCLEKSSSSSSQPEHSAMLVSTAASPSLIKETTTGYYKDIVENICGREKSGIQPLCPERSHISDQSPLSSKRKALEESESSQLISPPLAQAIRDYVNSLLVQGGVGSLPGTSNSMPPLDVENIQKRIDQSKFQETEFLSPPRKVPRLSEKSVEERDSGSFVAFQNIPGSELMSSFAKTVVSHSLTTLGLEVAKQSQHDKIDASELSFPFHESILKVIEEEWQQVDRQLPSLACKYPVSSREATQILSVPKVDDEILGFISEATPLGGIQAASTESCNQQLDLALCRAYEAAASALQIATHTAFVAKAMQADISQAAQILSSDPSRTHQALGILSKTYDAASYICEAAFDEVKMAAHTMGNATVGRRYLWLKDCKINLASKNKLASTPFKGGTLFGGEVCKVIKKRGNKH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

